Boston Scientific Corp.

NYSE:BSX   3:59:50 PM EDT
+0.13 (+0.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)56.77B
Current PE70.09
Forward PE 22.48
2yr Forward PE 19.8
See more stats
Estimates Current Quarter
Revenue$3.23 Billion
Adjusted EPS$0.43
See more estimates
10-Day MA$40.14
50-Day MA$43.00
200-Day MA$43.10
See more pivots

Boston Scientific Corp. Stock, NYSE:BSX

300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234
United States of America
Phone: +1.508.683.4000
Number of Employees: 41000


Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment consists of technologies for diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.